• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内肿块型胆管癌:使用钆塞酸二钠增强磁共振成像是否具有额外的预后价值?

Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?

作者信息

Halskov Sebastian, Krenzien Felix, Segger Laura, Geisel Dominik, Hamm Bernd, Pelzer Uwe, Ihlow Jana, Schöning Wenzel, Auer Timo Alexander, Fehrenbach Uli

机构信息

Department of Radiology, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

Berlin Institute of Health, Anna-Louisa-Karsch-Straße 2, 10178 Berlin, Germany.

出版信息

Cancers (Basel). 2024 Mar 28;16(7):1314. doi: 10.3390/cancers16071314.

DOI:10.3390/cancers16071314
PMID:38610992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11011032/
Abstract

OBJECTIVE

To investigate the prognostic value of enhancement patterns of intrahepatic mass-forming cholangiocarcinomas (IMCCs) during the hepatobiliary phase (HBP) in gadoxetic acid (Gd-EOB)-enhanced MRI.

METHODS

We retrospectively identified 66 consecutive patients with histopathologically proven IMCCs (reference standard: resection) and preoperative Gd-EOB-enhanced MRI. Gd-EOB retention area was subjectively rated based on areas of intermediate signal intensity. Lesions were classified as either hypointense (0-25% retention area) or significantly-retaining (>25% retention area). Clinical, radiological, and prognostic features were compared between these groups. The primary endpoints were recurrence-free survival (RFS) and overall survival (OS) after primary surgical resection.

RESULTS

73% (48/66) of lesions were rated as hypointense and 29% (19/66) as significantly-retaining. While the hypointense subgroup more frequently featured local and distant intrahepatic metastases ( = 0.039 and = 0.022) and an infiltrative growth pattern ( = 0.005), RFS, OS, and clinical features did not differ significantly with estimated Gd-EOB retention area or quantitatively measured HBP enhancement ratios. Lymph node metastasis was an independent predictor of poor RFS ( = 0.001).

CONCLUSIONS

Gd-EOB-enhanced MRI revealed two subtypes of IMCC in the HBP: hypointense and signal-retaining. The hypointense subtype is associated with more frequent intrahepatic metastases and an infiltrative growth pattern, indicating potential tumor aggressiveness. However, this did not result in a significant difference in survival after the primary resection of IMCC.

摘要

目的

探讨钆塞酸二钠(Gd-EOB)增强磁共振成像(MRI)肝胆期(HBP)肝内肿块型胆管癌(IMCC)强化模式的预后价值。

方法

我们回顾性纳入了66例经组织病理学证实为IMCC(参考标准:手术切除)且术前行Gd-EOB增强MRI检查的连续患者。基于中等信号强度区域对Gd-EOB滞留面积进行主观评分。病变分为低信号(滞留面积0-25%)或显著滞留(滞留面积>25%)。比较两组的临床、影像学和预后特征。主要终点为初次手术切除后的无复发生存期(RFS)和总生存期(OS)。

结果

73%(48/66)的病变被评为低信号,29%(19/66)为显著滞留。虽然低信号亚组更常出现肝内局部和远处转移(P = 0.039和P = 0.022)以及浸润性生长模式(P = 0.005),但RFS、OS和临床特征与估计的Gd-EOB滞留面积或定量测量的HBP强化率无显著差异。淋巴结转移是RFS差的独立预测因素(P = 0.001)。

结论

Gd-EOB增强MRI在HBP期显示出IMCC的两种亚型:低信号型和信号滞留型。低信号亚型与更频繁的肝内转移和浸润性生长模式相关,提示潜在的肿瘤侵袭性。然而,这并未导致IMCC初次切除后生存期的显著差异。

相似文献

1
Intrahepatic Mass-Forming Cholangiocarcinoma: Is There Additional Prognostic Value in Using Gd-EOB Enhanced MRI?肝内肿块型胆管癌:使用钆塞酸二钠增强磁共振成像是否具有额外的预后价值?
Cancers (Basel). 2024 Mar 28;16(7):1314. doi: 10.3390/cancers16071314.
2
Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.肝内肿块型胆管细胞癌:术前钆塞酸增强 MRI 的预后价值。
Eur Radiol. 2016 Feb;26(2):407-16. doi: 10.1007/s00330-015-3846-5. Epub 2015 May 23.
3
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.钆塞酸二钠增强 MRI 成像对肝内胆管细胞癌的影像学特征。
Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.
4
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
5
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.肝内肿块型胆管细胞癌:钆塞酸增强磁共振成像的增强模式。
Radiology. 2012 Sep;264(3):751-60. doi: 10.1148/radiol.12112308. Epub 2012 Jul 12.
6
Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.肝细胞癌患者钆乙氧基苄基二乙三胺五乙酸增强磁共振成像上非高血管性低信号结节的存在情况
J Gastroenterol Hepatol. 2017 Apr;32(4):908-915. doi: 10.1111/jgh.13622.
7
Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?肝细胞腺瘤:钆塞酸二钠增强 MRI 在亚型鉴别方面是否具有附加价值?
Eur Radiol. 2020 Jun;30(6):3497-3506. doi: 10.1007/s00330-020-06726-8. Epub 2020 Feb 21.
8
Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus.使用钆塞酸二钠增强磁共振成像结合血清标志物鉴别乙型肝炎病毒高危患者的肿块型肝内胆管癌与非典型肝细胞癌
Quant Imaging Med Surg. 2023 Oct 1;13(10):7156-7169. doi: 10.21037/qims-23-396. Epub 2023 Sep 5.
9
Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.钆乙氧基苄基二亚乙基三胺五乙酸增强磁共振成像肝胆期非高血管性低信号肝结节作为肝细胞癌射频消融术后肝内远处复发的危险因素
Dig Dis. 2017;35(6):574-582. doi: 10.1159/000480185. Epub 2017 Oct 17.
10
Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.优化CT和MRI标准以鉴别肝内肿块型胆管癌和肝细胞癌。
Acta Radiol. 2023 Mar;64(3):926-935. doi: 10.1177/02841851221113265. Epub 2022 Jul 27.

引用本文的文献

1
An Unusual Radiologic Image of Extensive Tumor Mass Infiltrating Hepatic Hilum without Signs of Cholestasis-A Case Report and a Literature Review of Non-Cancerous Lesions Mimicking Intrahepatic Cholangiocarcinoma.广泛肿瘤浸润肝门而无胆管扩张征象的不典型影像学表现:1 例报告并文献复习非癌性病变酷似肝内胆管细胞癌
Curr Oncol. 2024 Aug 4;31(8):4507-4518. doi: 10.3390/curroncol31080336.

本文引用的文献

1
Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.术前基于磁共振成像的肝内胆管细胞癌的亚分类。
Cancer Imaging. 2023 Feb 13;23(1):15. doi: 10.1186/s40644-023-00533-2.
2
R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma?R1 血管或实质切缘:肝内胆管癌切除术后的影响是什么?
Cancers (Basel). 2022 Oct 20;14(20):5151. doi: 10.3390/cancers14205151.
3
Impact of small duct- and large duct type on survival in patients with intrahepatic cholangiocarcinoma: Results from a German tertiary center.
小胆管型和大胆管型对肝内胆管癌患者生存的影响:来自德国一家三级中心的结果。
Pathol Res Pract. 2022 Oct;238:154126. doi: 10.1016/j.prp.2022.154126. Epub 2022 Sep 16.
4
Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value.利用肝脏磁共振成像特征对肝内胆管癌进行亚型分类及其预后价值
Liver Cancer. 2022 Mar 30;11(3):233-246. doi: 10.1159/000521747. eCollection 2022 Jun.
5
Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.肝内胆管癌的治疗——多学科方法
Cancers (Basel). 2022 Jan 12;14(2):362. doi: 10.3390/cancers14020362.
6
Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).MRI 联合动脉期和延迟期增强模式有助于预测肝内肿块型胆管细胞癌(IMCC)的预后。
Abdom Radiol (NY). 2022 Feb;47(2):640-650. doi: 10.1007/s00261-021-03292-5. Epub 2021 Nov 25.
7
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.经皮肝穿刺活检术在慢性肝病中的并发症发生率:一项系统评价和荟萃分析。
Dig Dis Sci. 2022 Jul;67(7):3366-3394. doi: 10.1007/s10620-021-07089-w. Epub 2021 Jun 15.
8
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.美国和欧洲胆管癌的临床管理:指南的全面循证比较
Ann Surg Oncol. 2021 May;28(5):2660-2674. doi: 10.1245/s10434-021-09671-y. Epub 2021 Mar 1.
9
HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.增强型肝细胞腺瘤及其在钆塞酸增强 MRI 中的与 FNH 鉴别
BMC Med Imaging. 2021 Feb 15;21(1):28. doi: 10.1186/s12880-021-00552-0.
10
Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.弥散加权 MRI 表观弥散系数对肿块型肝内胆管细胞癌的预后预测价值。
J Hepatobiliary Pancreat Sci. 2020 Jul;27(7):388-395. doi: 10.1002/jhbp.732. Epub 2020 Apr 6.